Advertisement
UK markets open in 48 minutes
  • NIKKEI 225

    37,636.54
    -823.54 (-2.14%)
     
  • HANG SENG

    17,215.29
    +14.02 (+0.08%)
     
  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     
  • GOLD FUTURES

    2,330.40
    -8.00 (-0.34%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,510.25
    -1,910.58 (-3.58%)
     
  • CMC Crypto 200

    1,390.07
    +7.50 (+0.54%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?

What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?

SCYNEXIS (SCYX) witnessed a 28% rise in its stock price in the week ended May 18. On May 18, SCYNEXIS stock closed at $1.63, which is ~14.4% growth from its previous close of $1.43 on May 17. SCYNEXIS stock rose ~27% over the last month. SCYNEXIS is a biotechnology company focused on the development of innovative therapies for the treatment of patients with difficult-to-treat and life-threatening infections.